跳至主要内容
临床试验/JPRN-UMIN000004553
JPRN-UMIN000004553已完成未知

Treatment of paroxysmal atrial fibrillation with pill-in-the-pocket approach-comparison of propafenone and flecainide- - F-PITPA study

Fujita Health University School of Medicine0 个研究点目标入组 50 人开始时间: 2010年11月13日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients were excluded if they had one or more of the following findings: electrocardiographic evidence of ventricular pre-excitation or bundlebranch block (QRS interval >120 msec), a previous episode of atrial fibrillation lasting seven days or more, ischemic heart disease, dilated or hypertrophic cardiomyopathy, a history of heart failure, severe valvular heart disease, chronic cor pulmonale, left ventricular dysfunction (ejection fraction, 50 percent), a long QT interval or the Brugada syndrome, the bradycardia-tachycardia syndrome (resting heart rate, 50 beats per minute, or repetitive sinoatrial blocks during waking hours), documentation of previous episodes of second or third-degree atrioventricular block, previous thromboembolic episodes, acute disease, very severe chronic diseases (e.g., muscular dystrophies or systemic collagen diseases), renal or hepatic insufficiency, previous hypokalemia (potassium level, <3 mmol per liter), suspected or known pregnancy, a known intolerance of flecainide or current propafenone, or current prophylactic antiarrhythmic treatment.

研究者

发起方
Fujita Health University School of Medicine

相似试验

Treatment of paroxysmal atrial fibrillation with... | 临床试验